Xueyin Wang

Xueyin Wang has a diverse work experience in the field of biomedical sciences. They currently hold the position of Principal Scientist at Generate:Biomedicines since July 2023. Prior to that, Xueyin held various roles at A2 Biotherapeutics, Inc., including Principal Scientist from October 2022 to June 2023, Senior Scientist from January 2021 to September 2022, Scientist II from January 2020 to December 2020, and Scientist I from January 2018 to December 2019. Xueyin also worked as a Postdoctoral Researcher at the University of Colorado Boulder from May 2017 to December 2017, and as a Doctoral Researcher from August 2012 to April 2017. They conducted their doctoral research on the molecular basis of RNA recognition and transcriptional regulation by FUS and PRC2 under the guidance of Prof. Thomas Cech in the Department of Chemistry and Biochemistry. Additionally, Xueyin gained research experience as an Undergraduate Research Assistant at the University of Toronto from May 2009 to June 2011.

Xueyin Wang completed a Bachelor of Science (B.S.) degree in Biochemistry from the University of Toronto. Later, they pursued a Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Colorado Boulder.